Condition
Pelvis Pain Chronic
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Completed2
Terminated1
Withdrawn1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02160483Not ApplicableWithdrawnPrimary
Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain
NCT01451606Phase 4TerminatedPrimary
Duloxetine for the Treatment of Chronic Pelvic Pain
NCT02356796Not ApplicableCompletedPrimary
Chronic Pelvic Pain in Women - Conservative Group Treatment Compared to Standard Conservative Treatment.
NCT01635205Phase 4Completed
Paraspinous Anesthetic Block for Non-Responsive Pelvic Pain
Showing all 4 trials